Skip to main content
Premium Trial:

Request an Annual Quote

GenoLogics Life Sciences ProteusLIMS 2.5 and Bruker Daltonics Electron Transfer Dissociation Module

Premium

GenoLogics Life Sciences announced today the introduction of ProteusLIMS 2.5, a software platform for proteomics and systems biology research.

The new version of the ProteusLIMS features improved flexibility in configuring novel workflow processes on the fly, and in automating data capture for end-to-end lab process, research workflow and data integration, the company said.

The new ProteusLIMS 2.5 will be showcased at the American Society of Mass Spectrometry conference in San Antonio, Texas from June 5 — 9.


Bruker Daltonics announced this week the launch of its Electron Transfer Dissociation module designed to work with its ion trap mass spectrometer, HCTultra. The module fragments peptides and proteins in a way that preserves functionally important post-translational modifications, such as phosphorylation or glycosylaton.

The ETD technique on the HCTultra will be presented at the American Society of Mass Spectrometry conference from June 5 — 9.

The Scan

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.

Machine Learning Improves Diagnostic Accuracy of Breast Cancer MRI, Study Shows

Combining machine learning with radiologists' interpretations further increased the diagnostic accuracy of MRIs for breast cancer, a Science Translational Medicine paper finds.

Genome Damage in Neurons Triggers Alzheimer's-Linked Inflammation

Neurons harboring increased DNA double-strand breaks activate microglia to lead to neuroinflammation like that seen in Alzheimer's disease, a new Science Advances study finds.

Long COVID-19 Susceptibility Clues Contained in Blood Plasma Proteome

A longitudinal study in eBioMedicine found weeks-long blood plasma proteome shifts after SARS-CoV-2 infection, along with proteomic signatures that appeared to coincide with long Covid risk.